Spending power
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Brand profile · Biotechnology Research
BluMaiden Biosciences runs a Biotechnology Research operation from Singapore. Privately held, at blumaiden.com. It holds one address on record, all in Singapore. It employs 9 people, on the record. It lists artificial intelligence, biotechnology and clinical trials among its specialties. One Singapore registration (UEN) is a confirmed match. Its latest round on record is Grant, with no amount recorded. The record links eight similar brands, most of them in Biotechnology Research.
UEN202024052R
| BLUMAIDEN BIOSCIENCES PTE. LTD. | UEN 202024052R |
|---|---|
| Confirmed matches | 1 of 1 |
A candidate is a name match on the registry, not a confirmed identity, and two candidates are ambiguity rather than a corporate structure.
BluMaiden Biosciences is a biotech therapeutics platform company with the goal of revealing chemical dark matter to generate new medicines.
BluMaiden is uncovering the body’s uncharted chemical landscape — a vast repertoire of natural product small molecules hidden within human biology. We believe these human-derived natural products represent one of the most promising sources for the next generation of therapeutics — safer, more effective, and inherently aligned with our biology.
Unlike synthetic compounds, human natural product–derived molecules have been refined by evolution for stability, specificity, and biocompatibility — giving us a unique advantage in discovering therapies that are both potent and safe. BluMaiden is unlocking this hidden reservoir of bioactive chemistry through advanced AI-guided discovery and computational chemistry, translating this “chemical dark matter” into entirely new classes of medicines.
2 reported addresses · 1 on record.
| Countries | 1 |
|---|
All codes: SG
| Rounds | 1 |
|---|---|
| Axis | 2020 to 2026 |
| Grant · 1 Jun 2024 | not disclosed |
Dated rounds only. The axis ends at the date this profile was last observed, not at today.
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Hiring, headcount and registry-change signals, streamed to members.
Registry-filed capital and financial indicators, standardised by TheGrid.
4 employee profiles on record · names withheld.
Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.
The people relation is never requested, so there is nothing here to unlock.
One Singapore entity on ACRA: BLUMAIDEN BIOSCIENCES PTE. LTD. (UEN 202024052R), high confidence.
9 counted staff profiles at January 2026. The brand's self-reported band sits above that count and is not published as a headcount.
One address on record, Singapore only.
One round. Latest 1 June 2024: grant, investor Cedars-Sinai Accelerator, no amount recorded.
17 tags on the brand's own list, among them artificial intelligence, biotechnology and clinical trials.
12 profiles list BluMaiden Biosciences as a peer — 85th percentile in Biotechnology Research. It lists ten peers of its own. Singzyme and Lion TCR list it back.